Hamzah Syed
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Nicotinamide N-methyltransferase as a therapeutic target in taxane-resistant castration-resistant prostate cancer.
Journal: Cell death discovery
Published: September 25, 2025
Menin-driven mTOR signaling sustains taxane resistance in CRPC and reveals a targetable vulnerability for combination therapy.
Journal: Cell communication and signaling : CCS
Published: July 15, 2025
Butyrylcholinesterase (BChE) downregulation in taxane resistance: implications for prostate cancer.
Journal: Turkish journal of biology = Turk biyoloji dergisi
Published: February 24, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.
Journal: Experimental & molecular medicine
Published: April 18, 2024
A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming.
Journal: Communications biology
Published: January 29, 2024
Metabolomics profiling for diagnosis of acute renal failure after cardiopulmonary bypass.
Journal: Rapid communications in mass spectrometry : RCM
Published: October 31, 2023
Exploiting epigenetic targets to overcome taxane resistance in prostate cancer.
Journal: Cell death & disease
Published: September 13, 2023
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Journal: Cell communication and signaling : CCS
Published: May 02, 2023
Design and Adoption of Low-Cost Point-of-Care Diagnostic Devices: Syrian Case.
Journal: Micromachines
Published: June 07, 2021
SurvivalGWAS_SV: software for the analysis of genome-wide association studies of imputed genotypes with "time-to-event" outcomes.
Journal: BMC bioinformatics
Published: February 10, 2017
Last Updated: 09/26/2026